ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.55
0.20%
After-hours: Aug 15, 2025, 05:47 PM EDT

ImmunityBio Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.32 -4.38 -4.86 -6.76
PEG Ratio
0.09 -0.41 -0.31 -0.13
PS Ratio
121.07 4.11K 8.45K 2.53K
PB Ratio
-3.66 -4.35 -4.53 -9.77
P/FCF Ratio
-4.48 -6.43 -4.64 -7.68
P/OCF Ratio
-4.56 -6.96 -6.01 -8.62
OCF/S Ratio
-26.53 -589.64 -1.41K -293.81
Debt / Equity Ratio
-1.03 -1.24 -1.62 -2.67
Quick Ratio
3.21 5.05 0.23 0.91
Current Ratio
3.36 5.05 0.28 0.91
Asset Turnover
0.04 0.00 0.00 0.00
Interest Coverage
-2.23 -2.8 -5.53 -22.24
Return on Equity
0.85 0.99 0.93 1.44
Return on Assets
-1.08 -1.16 -1.15 -0.75
Return on Invested Capital
-1.02 -0.8 -1.19 -0.82
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 -99.8 1.00
Net Profit Margin
-28.05 -937.61 -1.74K -374.57
Pretax Profit Margin
-28.05 -938.73 -1.74K -374.56
Operating Profit Margin
-23.34 -582.4 -1.46K -353.62
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-16.4 -701.26 -1.4K -337.67